Chase Pharmaceuticals Corporation
Latest round
- Series B
Last raised
- Aug 2015
Total raised
- $10M
Investors
- 4
About Chase Pharmaceuticals Corporation
Founded in 2007 in Washington, US, Chase Pharmaceuticals Corporation specializes in creating treatments for neurological conditions. The company has undergone significant growth and was involved in a notable Trade Sale in November 2016, where Allergan Inc acquired a stake from Cipla Ventures for USD 125 mn. Chase has completed a total of 4 deals since its inception.Chase Pharmaceuticals Corporation is dedicated to the research and development of advanced therapies targeting neurological disorders. Their product focus is on creating innovative solutions that address complex health challenges faced by patients with such conditions.Chase Pharmaceuticals generates revenue through the strategic partnerships and collaborations established for the distribution of its therapies. By focusing on innovative treatments for neurological disorders, the company aims to enhance its market presence and revenue streams in the biopharmaceutical landscape. The company plans to explore expansion into additional markets, aiming for growth in North America and Europe by 2025. The recent Trade Sale of USD 125 mn will be utilized to support the launch of upcoming products, enhancing their portfolio and meeting patient needs.
Who invested in Chase Pharmaceuticals Corporation
4 investors across 3 rounds
See all investors in Chase Pharmaceuticals Corporation
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Chase Pharmaceuticals Corporation
Who invested in Chase Pharmaceuticals Corporation?
Chase Pharmaceuticals Corporation has 4 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Chase Pharmaceuticals Corporation raised?
Chase Pharmaceuticals Corporation has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Chase Pharmaceuticals Corporation last raise money?
Chase Pharmaceuticals Corporation's most recent round on record is a Series B, in Aug 2015.
What does Chase Pharmaceuticals Corporation do?
Founded in 2007 in Washington, US, Chase Pharmaceuticals Corporation specializes in creating treatments for neurological conditions.
Where is Chase Pharmaceuticals Corporation headquartered?
Chase Pharmaceuticals Corporation is headquartered in Washington, US.
Which VCs invest in companies like Chase Pharmaceuticals Corporation?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Chase Pharmaceuticals Corporation's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Chase Pharmaceuticals Corporation? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.